City of Hope
Deputy Director, T Cell Therapeutics Research Laboratory (TCTRL)
Heritage Provider, Network in Immunotherapy
Dr. Brown provides scientific oversight for the translational research programs and ongoing clinical trials evaluating CAR T cell therapy at City of Hope. Her efforts to develop glioblastoma-targeted CAR T cells, improve T cell manufacturing, and optimize routes of T cell delivery have led to the initiation of several first-in-human clinical trials. Dr. Brown’s ongoing research efforts also aim to develop strategies to limit tumor antigen escape and to overcome the suppressive tumor microenvironment, critical challenges limiting the effectiveness of CAR T cell therapy for treatment of solid tumors.
Dr. Brown received her doctoral degree from the University of California, Berkeley, and was a Leukemia & Lymphoma Scholar during her post-doctoral fellowship at Pennsylvania State University. Her scientific contributions in the development and optimization of tumor-specific CAR T cells for the treatment of brain tumors are supported by the California Institute for Regenerative Medicine (CIRM), National Institutes of Health, Ivy Foundation, Gateway for Cancer Research, Rising Tide and Norris Foundation.
Wang Z, et al. Cell Stem Cell.2022
Stern L, et al, PNAS, 2022
Wang D, et al. Cancer Discov. 2021
Alizadeh D, et al. Cancer Discov. 2021
Portnow J, et al. JAMA Oncol. 2020
Wang D, et al. Sci. Transl. Med. 2020
Zah E, et al. Nat Commun. 2020
Alizadeh D, et al. Cancer Immunol Res. 2019
Brown CE, et al. N Engl J Med. 2016
The First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang Society for Immunology
? Copyright Cell Research Symposium - All rights reserved.